Company overview Financial review 2022 priorities Appendix References 1 Investor Relations │ Q2 2022 Results 台 Q2 2022 Results Investor presentation U NOVARTIS | Reimagining Medicine Company overview Financial review 2022 priorities Appendix References 2 NOVARTIS Q2 RESULTS | JULY 19, 2022 | NOVARTIS INVESTOR PRESENTATION Disclaimer This presentation contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, that can generally be identified ...